Skip to main content
Springer Nature Link
Log in

Pituitary adenomas

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Treatment of pituitary adenomas can be pharmacologic or surgical. First-line treatment of prolactinomas is usually medical, using either bromocriptine or cabergoline. Other symptomatic pituitary adenomas typically should be treated with transsphenoidal surgery. Radiation therapy can be adjunctive for residual or recurrent tumor. The prognosis for endocrinologic and visual improvement is usually good.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Abboud CF, Laws EJ: Diagnosis of pituitary tumors. Endocrinol Metab Clin North Am 1988, 17:241–280.

    PubMed  CAS  Google Scholar 

  2. Post KD, Muraszko K: Management of pituitary tumors. Neurol Clin 1986, 4:801–831.

    PubMed  CAS  Google Scholar 

  3. Teramoto A, Hirakawa K, Sanno N, et al.: Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 1994, 193:161–164.

    PubMed  CAS  Google Scholar 

  4. Di Rocco C, Maira G, Borelli P: Pituitary microadenomas in children. Childs Brain 1982, 9:165–178.

    Article  PubMed  Google Scholar 

  5. Shalet SM: Pituitary adenomas in childhood. Acta Endocrinol Suppl (Copenh) 1986, 279:434–439.

    CAS  Google Scholar 

  6. Faglia G: Epidemiology and pathogenesis of pituitary adenomas. Acta Endocrinol (Copenh) 1993, 1:1–5.

    Google Scholar 

  7. Lee AG, Sforza PD, Fard AK, et al.: Pituitary adenoma in children. J Neuro-ophthalmol 1998, 18:102–105.

    CAS  Google Scholar 

  8. Abe T, Lüdecke DK, Saeger W: Clinically nonsecreting pituitary adenomas in childhood and adolescence. Neurosurgery 1998, 42:744–750.

    Article  PubMed  CAS  Google Scholar 

  9. Alford FP, Arnott R: Medical management of pituitary tumours. Med J Aust 1992, 157:57–60.

    PubMed  CAS  Google Scholar 

  10. Keltner JI, Gittinger JW, Burde RM, et al.: Endocrinological associations of pituitary tumors. Surv Ophthalmol 1980, 25:31–36.

    Article  PubMed  CAS  Google Scholar 

  11. Simcic KJ, Moreno AJ: Tumors of the pituitary, pancreas, and parathyroid glands in a patient with multiple endocrine neoplasia Type 1. N Engl J Med 1998, 339:1602.

    Article  PubMed  CAS  Google Scholar 

  12. Elster AD: Modern imaging of the pituitary. Radiology 1993, 187:1–14.

    PubMed  CAS  Google Scholar 

  13. Vance ML: Hypopituitarism. N Engl J Med 1994, 330:1651–1661.

    Article  PubMed  CAS  Google Scholar 

  14. Klibanski A: Nonsecreting pituitary tumors. Endocrinol Metab Clin North Am 1987, 16:793–804.

    PubMed  CAS  Google Scholar 

  15. Sassolas G, Trouillas J, Treluyer C, et al.: Management of nonfunctioning pituitary adenomas. Acta Endocrinol (Copenh) 1993, 129(suppl):21–26.

    Google Scholar 

  16. Gsponer J, De Tribolet N, Déruaz JP, et al.: Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine 1999, 78:236–269. A large review of sellar masses seen consecutively at one institution.

    Article  PubMed  CAS  Google Scholar 

  17. Vance ML, Thorner MO: Prolactinomas. Endocrinol Metab Clin North Am 1987, 16:731–753.

    PubMed  CAS  Google Scholar 

  18. Kovacs K, Horvath E: Pathology of pituitary tumors. Endocrinol Metab Clin North Am 1987, 16:529–551.

    PubMed  CAS  Google Scholar 

  19. Bevan JS, Webster J, Burke CW, et al.: Dopamine agonists and pituitary tumor shrinkage. Endocrine Rev 1992, 13:220–240.

    Article  CAS  Google Scholar 

  20. Elkington SG: Pituitary adenoma: preoperative symptomatology in a series of 260 patients. Br J Ophthalmol 1968, 52:322–328.

    PubMed  CAS  Google Scholar 

  21. Kucharczyk W, Montanera WJ: The sella and parasellar region. In Magnetic Resonance Imaging of the Brain and Spine. Edited by Atlas SW. New York: Raven Press; 1991:625–667.

    Google Scholar 

  22. Ostrov SG, Quencer RM, Hoffman JC, et al.: Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? AJNR Am J Neuroradiol 1989, 10:503–510.

    Google Scholar 

  23. Cottier JP, Destrieux C, Brunereau L, et al.: Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology 2000, 215:463–469.

    PubMed  CAS  Google Scholar 

  24. Aron DC, Tyrrell JB, Wilson CB: Pituitary tumors: current concepts in diagnosis and management. West J Med 1995, 162:340–352.

    PubMed  CAS  Google Scholar 

  25. Besser M: Criteria for medical as opposed to surgical treatment of prolactinomas. Acta Endocrinol (Copenh) 1993, 129(suppl):27–30.

    Google Scholar 

  26. Baumann G: Acromegaly. Endocrinol Metab Clin North Am 1987, 16:685–703.

    PubMed  CAS  Google Scholar 

  27. Orth DN: Cushing’s syndrome. N Engl J Med 1995, 332:791–803.

    Article  PubMed  CAS  Google Scholar 

  28. Grochowicki M, Khafallah Y, Vighetto A, et al.: Ophthalmic results in patients with macroprolactinomas treated with a new prolactin inhibitor CV 205-502. Br J Ophthalmol 1993, 77:785–788.

    PubMed  CAS  Google Scholar 

  29. Serri O: Progress in the management of hyperprolactinemia [editorial]. N Engl J Med 1994, 331:942–944.

    Article  PubMed  CAS  Google Scholar 

  30. Jaquet P: Medical therapy of prolactinomas. Acta Endocrinol (Copenh) 1993, 129(suppl):31–33.

    Google Scholar 

  31. Moster ML, Savino PJ, Schatz NJ, et al.: Visual function in prolactinoma patients treated with bromocriptine. Ophthalmology 1985, 92:1332–1341.

    PubMed  CAS  Google Scholar 

  32. Lesser RL, Zheutlin JD, Boghen D, et al.: Visual function improvement in patients with macroprolactinomas treated with bromocriptine. Am J Ophthalmol 1990, 109:535–543.

    PubMed  CAS  Google Scholar 

  33. Mbanya J-CN, Mendelow AD, Crawford PJ, et al.: Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas. Br J Neurosurg 1993, 7:519–527.

    PubMed  CAS  Google Scholar 

  34. Ozgen T, Oruckaptan HH, Ozcan OE, et al.: Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature. Acta Neurochir 1999, 141:1287–1294.

    Article  CAS  Google Scholar 

  35. Webster J, Piscitelli G, Polli A, et al.: A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 1994, 331:904–909.

    Article  PubMed  CAS  Google Scholar 

  36. Cannavo S, Curto L, Squadrito S, et al.: Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma. J Endocrinol Invest 1999, 22:354–359. A prospective study of the efficacy of cabergoline in prolactinomas.

    PubMed  CAS  Google Scholar 

  37. Di Sarno A, Landi ML, Marzullo P, et al.: The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol 2000, 53:53–60. A prospective study of the efficacy of quinagolide and cabergoline in prolactinomas.

    Article  Google Scholar 

  38. Laws ER: Pituitary surgery. Endocrinol Metab Clin North Am 1987, 16:647–665.

    PubMed  Google Scholar 

  39. Ebersold MJ, Quast LM, Laws ER, et al.: Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 1986, 64:713–719.

    PubMed  CAS  Google Scholar 

  40. Jho HD, Carrau RL, Ko Y, et al.: Endoscopic pituitary surgery: an early experience. Surg Neurol 1997, 47:213–222.

    Article  PubMed  CAS  Google Scholar 

  41. Yaniv E, Rappaport ZH: Endoscopic transeptal transsphenoidal surgery for pituitary tumors. Neurosurgery 1997, 40:944–946.

    Article  PubMed  CAS  Google Scholar 

  42. Sheehan MT, Atkinson JLD, Kasperbauer JL: Preliminary comparison of the endoscopic transnasal vs. the sublabial approach for clinically nonfunctioning pituitary macroadenomas. Mayo Clin Proc 1999, 74:661–670.

    Article  PubMed  CAS  Google Scholar 

  43. Dolenc VV, Lipovsek M, Slokan S: Traumatic aneurysm and carotid-cavernous fistula following transsphenoidal approach to a pituitary adenoma: treatment by transcranial operation. Br J Neurosurg 1999, 13:185–188.

    Article  PubMed  CAS  Google Scholar 

  44. Ciric I, Ragin A, Baumgartner C, et al.: Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 1997, 40:225–236.

    Article  PubMed  CAS  Google Scholar 

  45. Oruckaptan HH, Senmevsim O, Ozcan OE, et al.: Pituitary adenomas: results of 684 surgically treated patients and review of the literature. Surg Neurol 2000, 53:211–219. Review of a large experience with pituitary adenomas at one center.

    Article  PubMed  CAS  Google Scholar 

  46. Czech T, Wolfsberger S, Reitner A, et al.: Delayed visual deterioration after surgery for pituitary adenoma. Acta Neurochirurg 1999, 141:45–51.

    Article  CAS  Google Scholar 

  47. Arafah BM, Brodkey JS, Manni A, et al.: Recovery of pituitary function following surgical removal of large nonfunctioning pituitary adenomas. Clin Endocrinol 1982, 17:213–222.

    CAS  Google Scholar 

  48. Adams CB, Burke CW: Current modes of treatment of pituitary tumours [editorial]. Br J Neurosurg 1993, 7:123–127.

    PubMed  CAS  Google Scholar 

  49. Breen P, Flickinger JC, Kondziolka D, et al.: Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 1998, 89:933–938.

    Article  PubMed  CAS  Google Scholar 

  50. Plowman PN: Pituitary adenoma radiotherapy: when, who and how? Clin Endocrinol 1999, 51:265–271.

    Article  CAS  Google Scholar 

  51. Sasaki R, Murakami M, Okamoto Y, et al.: The efficacy of conventional radiation therapy in the management of pituitary adenoma. Int J Radiation Oncology Biol Phys 2000, 47:1337–1345. A retrospective review of 91 patients with pituitary adenoma treated with radiation therapy.

    Article  CAS  Google Scholar 

  52. Brada M, Burchell L, Ashley S, et al.: The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiation Oncology Biol Phys 1999, 45:693–698.

    Article  CAS  Google Scholar 

  53. Jalali R, Brada M, Perks JR, et al.: Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience. Clin Endocrinol 2000, 52:695–702.

    Article  CAS  Google Scholar 

  54. Cardoso ER, Peterson EW: Pituitary apoplexy: a review. Neurosurgery 1984, 14:363–373.

    Article  PubMed  CAS  Google Scholar 

  55. Randeva HS, Schoebel J, Byrne J, et al.: Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol 1999, 51:181–188.

    Article  CAS  Google Scholar 

  56. Aron DC, Howlett TA: Pituitary incidentalomas. Endocrinol Metabol Clin N Am 2000, 29:205–221.

    Article  CAS  Google Scholar 

  57. Molitch ME: Incidental pituitary adenomas. Am J Med Sci 1993, 306:262–264.

    Article  PubMed  CAS  Google Scholar 

  58. Molitch ME: Evaluation and treatment of the patient with a pituitary incidentaloma. J Clin Endocrinol Metab 1995, 80:3–6.

    Article  PubMed  CAS  Google Scholar 

  59. Molitch ME: Approach to the incidentally discovered pituitary mass. In Cancer Treatment and Research (Endocrine Neoplasms). Edited by Arnold A. Hingham, MA: Kluwer Academic; 1997:73–90.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neuro-ophthalmology, Department of Neurology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 19104, Philadelphia, PA, USA

    Grant T. Liu MD

Authors
  1. Grant T. Liu MD
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, G.T. Pituitary adenomas. Curr Treat Options Neurol 4, 261–269 (2002). https://doi.org/10.1007/s11940-002-0026-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-002-0026-0

Keywords